Network-Based Bioinformatics Highlights Broad Importance of Human Milk Hyaluronan

Kathryn Y Burge1, Hua Zhong1, Adam P Wilson1

  • 1Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

Insights

Human milk

Area of Science:

  • Neonatal development
  • Gastroenterology
  • Immunology

Background:

  • Human milk (HM) contains bioactive factors crucial for infant gut development.
  • Hyaluronan (HA), a glycosaminoglycan in HM, is linked to protection against necrotizing enterocolitis (NEC).
  • Specific molecular mechanisms of HA's protective effects on the neonatal ileum are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which 35 kDa hyaluronan (HA35) promotes intestinal maturation.
  • To investigate HA35's impact on ileal cell populations and signaling pathways in neonatal mice.
  • To identify potential pathways through which HA35 confers protection against NEC.

Main Methods:

  • CD-1 mouse pups were administered HA35 or vehicle control from postnatal day 7 to 14.
  • Bulk RNA sequencing of ileal transcriptomes was performed.
  • Network and functional analyses, including gene set enrichment and pathway analyses, were utilized.
  • Cell deconvolution was applied to analyze changes in ileal cell composition.

Main Results:

  • HA35 treatment led to distinct transcriptomic profiles compared to controls.
  • Cell deconvolution indicated increased proportions of stromal, Paneth, and mature enterocyte/progenitor cells.
  • Key pro-growth and differentiation pathways were upregulated, including oxidative stress response and mTOR signaling.
  • Apoptotic signaling pathways were downregulated in HA35-treated pups.

Conclusions:

  • HA35 promotes ileal maturation in neonatal mice by modulating cell populations and signaling pathways.
  • Upregulation of antioxidant, growth, and differentiation pathways, alongside downregulation of apoptosis, are key mechanisms.
  • These findings suggest HA35's potential as a therapeutic agent against NEC in preterm infants.